Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
BMJ Open
|
March 7, 2020
Impact of preterm birth on brain development and long-term outcome: protocol for a cohort study in Scotland
James P Boardman, Jill Hall, Michael J Thrippleton, et al.
BMJ Open
|
January 24, 2019
Adjuvant rituximab, a potential treatment for the young patient with Graves' hyperthyroidism (RiGD): study protocol for a single-arm, single-stage, phase II trial
Michael Cole, Ann Marie Hynes, Denise Howel, et al.
BMC Medicine
|
January 30, 2015
In utero exposure to cigarette chemicals induces sex-specific disruption of one-carbon metabolism and DNA methylation in the human fetal liver
Amanda J Drake, Peter J O'Shaughnessy, Siladitya Bhattacharya, et al.
Plos One
|
May 23, 2012
Proposed role for COUP-TFII in regulating fetal Leydig cell steroidogenesis, perturbation of which leads to masculinization disorders in rodents
Sander van den Driesche, Marion Walker, Chris McKinnell, et al.
BMJ Open
|
January 16, 2015
Efficacy of metformin in pregnant obese women: a randomised controlled trial
Carolyn A Chiswick, Rebecca M Reynolds, Fiona C Denison, et al.
The Journal of Physiology
|
May 31, 2025
The impact of metformin on placental ageing in humans and mice
Grace J Hattersley, Liu Yang, Jane L Tarry-Adkins, et al.
The Lancet. Diabetes & Endocrinology
|
July 14, 2015
Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial
Carolyn Chiswick, Rebecca M Reynolds, Fiona Denison, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
May 23, 2018
Modelling non-alcoholic fatty liver disease in human hepatocyte-like cells
Marcus J Lyall, Jessy Cartier, John P Thomson, et al.
Elife
|
December 30, 2014
Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4(+) T cells tolerized by peptide immunotherapy
Rhoanne C McPherson, Joanne E Konkel, Catriona T Prendergast, et al.
Cancer Research
|
May 20, 2016
Loss of Tet1-Associated 5-Hydroxymethylcytosine Is Concomitant with Aberrant Promoter Hypermethylation in Liver Cancer
John P Thomson, Raffaele Ottaviano, Elif B Unterberger, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
BMJ Open
|
March 7, 2020
Impact of preterm birth on brain development and long-term outcome: protocol for a cohort study in Scotland
James P Boardman, Jill Hall, Michael J Thrippleton, et al.
BMJ Open
|
January 24, 2019
Adjuvant rituximab, a potential treatment for the young patient with Graves' hyperthyroidism (RiGD): study protocol for a single-arm, single-stage, phase II trial
Michael Cole, Ann Marie Hynes, Denise Howel, et al.
BMC Medicine
|
January 30, 2015
In utero exposure to cigarette chemicals induces sex-specific disruption of one-carbon metabolism and DNA methylation in the human fetal liver
Amanda J Drake, Peter J O'Shaughnessy, Siladitya Bhattacharya, et al.
Plos One
|
May 23, 2012
Proposed role for COUP-TFII in regulating fetal Leydig cell steroidogenesis, perturbation of which leads to masculinization disorders in rodents
Sander van den Driesche, Marion Walker, Chris McKinnell, et al.
BMJ Open
|
January 16, 2015
Efficacy of metformin in pregnant obese women: a randomised controlled trial
Carolyn A Chiswick, Rebecca M Reynolds, Fiona C Denison, et al.
The Journal of Physiology
|
May 31, 2025
The impact of metformin on placental ageing in humans and mice
Grace J Hattersley, Liu Yang, Jane L Tarry-Adkins, et al.
The Lancet. Diabetes & Endocrinology
|
July 14, 2015
Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial
Carolyn Chiswick, Rebecca M Reynolds, Fiona Denison, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
May 23, 2018
Modelling non-alcoholic fatty liver disease in human hepatocyte-like cells
Marcus J Lyall, Jessy Cartier, John P Thomson, et al.
Elife
|
December 30, 2014
Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4(+) T cells tolerized by peptide immunotherapy
Rhoanne C McPherson, Joanne E Konkel, Catriona T Prendergast, et al.
Cancer Research
|
May 20, 2016
Loss of Tet1-Associated 5-Hydroxymethylcytosine Is Concomitant with Aberrant Promoter Hypermethylation in Liver Cancer
John P Thomson, Raffaele Ottaviano, Elif B Unterberger, et al.
Page
of 8